We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
GW Pharm. | LSE:GWP | London | Ordinary Share | GB0030544687 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 735.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMGWP TIDMPRU
RNS Number : 9783K
GW Pharmaceuticals PLC
30 June 2014
TR-1: NOTIFCATION OF MAJOR INTEREST IN SHARES ------------------------------------------------------------------------------------- 1. Identity of the issuer or the underlying GW Pharmaceuticals Plc issuer of existing shares to which voting rights are attached: (ii) ----------------------------------------------- ------------------------------------ 2 Reason for the notification (please tick the appropriate box or boxes): ------------------------------------------------------------------------------------- An acquisition or disposal of voting rights ---------------------------------------------------------------------------- ------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ---------------------------------------------------------------------------- ------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ---------------------------------------------------------------------------- ------- An event changing the breakdown of voting rights ---------------------------------------------------------------------------- ------- Other (please specify): X Update to Total Voting Rights figure triggered this notification ------------------------------------------------------------------------ ------- 3. Full name of person(s) subject Prudential plc group of companies to the notification obligation: (iii) ----------------------------------------- ------------------------------------------ 4. Full name of shareholder(s) See attached schedule (if different from 3.):(iv) ----------------------------------------- ------------------------------------------ 5. Date of the transaction and date 26 June 2014 on which the threshold is crossed or reached: (v) ----------------------------------------- ------------------------------------------ 6. Date on which issuer notified: 30 June 2014 ----------------------------------------- ------------------------------------------ 7. Threshold(s) that is/are crossed or reached: (vi, vii) 14% - 13% ----------------------------------------- ------------------------------------------ 8. Notified details: ------------------------------------------------------------------------------------------------------------------------------ A: Voting rights attached to shares (viii, ix) ------------------------------------------------------------------------------------------------------------------------------ Class/type Situation previous Resulting situation after the triggering of to the triggering transaction shares transaction if possible using the ISIN CODE ------------- -------------------------------------- ----------------------------------------------------------------------- Number Number Number Number of voting % of voting rights of of of shares rights (x) Shares Voting Rights ------------- --------------- --------------------- ------------- ------------------------- ----------------------------- Direct Direct Indirect Direct Indirect (xi) (xii) ------------- --- --- ----- ------ ----- --- ------------- -------------- --------- --------------- ------------ GB0030544687 21,490,529 21,490,529 21,490,529 21,490,529 0 9.09% 0 ------------- --------------- --------------------- ------------- -------------- --------- --------------- ------------ US36197T1034 870,905 10,450,860 870,905 10,450,860 0 4.42% 0 ------------- --------------- --------------------- ------------- -------------- --------- --------------- ------------ B: Qualifying Financial Instruments ------------------------------------------------------------------------------------------------------------------------------ Resulting situation after the triggering transaction ------------------------------------------------------------------------------------------------------------------------------ Type of financial Expiration Exercise/ Number of voting % of voting instrument date (xiii) Conversion Period rights that may rights (xiv) be acquired if the instrument is exercised/ converted. ----------------------- ---------------- -------------------------------- ----------------------------- ------------------ C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ------------------------------------------------------------------------------------------------------------------------------ Resulting situation after the triggering transaction ------------------------------------------------------------------------------------------------------------------------------ Type of financial Exercise Expiration Exercise/ Number of voting % of voting rights instrument price date (xvii) Conversion rights instrument (xix, xx) period refers to (xviii) ------------------ ------------- ------------- ------------------ ------------------------------ ------------------------ Nominal Delta ------------------ ------------- ------------- ------------------ ------------------------------ ------------- --------- Total (A+B+C) ------------------------------------------------------------------------------------------------------------------------------ Number of voting rights Percentage of voting rights ------------------------------------------------------------------ ---------------------------------------------------------- 31,941,389 13.51% ------------------------------------------------------------------ ---------------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) ---------------------------------------------------------------------------------- Prudential plc (parent Company) M&G Group Limited (wholly owned subsidiary of Prudential plc) M&G Limited (wholly owned subsidiary of M&G Group Limited) M&G Investment Management Limited (wholly owned subsidiary of M&G Limited) M&G Securities Limited (wholly owned subsidiary of M&G Limited) Proxy Voting: ---------------------------------------------------------------------------------- 10. Name of the proxy holder: N/A ----------------------------------------------------- --------------------------- 11. Number of voting rights proxy holder will N/A cease to hold: ----------------------------------------------------- --------------------------- 12. Date on which proxy holder will cease to N/A hold voting rights: ----------------------------------------------------- --------------------------- 13. Additional information: ----------------------------------------- --------------------------------------- 14. Contact name: Owen Smith / James Todd M&G Investment Management Limited ----------------------------------------- --------------------------------------- 15. Contact telephone number: 020 7004 4517 / 020 7548 2293 ----------------------------------------- ---------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLEAKKEDFFLEFF
1 Year Gw Pharmaceuticals Chart |
1 Month Gw Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions